Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults

NCT01755689 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1300

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: Meningococcal vaccine GSK134612
BIOLOGICAL: Cervarix®
BIOLOGICAL: Boostrix®

Sponsor

GlaxoSmithKline